Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × NIH × imetelstat × Clear all

Phase

Status

Sponsor Class

INDUSTRY 4 NETWORK 3 OTHER 1 NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Specimen Handling 87 Biopsy 74 Magnetic Resonance Spectroscopy 67 Cisplatin 51 Paclitaxel 48 Cyclophosphamide 48 Radiotherapy 45 Carboplatin 42 Gemcitabine 40 Irinotecan 36 Bortezomib 31 Taxes 29 Fluorouracil 28 Filgrastim 28 Doxorubicin 27 Radiation 26 Cytarabine 26 veliparib 25 Oxaliplatin 25 Vorinostat 24 Rituximab 24 Leucovorin 24 aldesleukin 23 Ipilimumab 23 Etoposide 23 alvocidib 22 Temozolomide 22 Erlotinib Hydrochloride 22 Bevacizumab 22 fludarabine phosphate 21

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01568632 2012-11-21

Imetelstat for Children With Refractory or Recurrent Solid Tumors and Lymphoma

National Institutes of Health Clinical Center (CC)

Phase 1 Withdrawn

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡